吴延娟 (Yanjuan Wu)
H指数:1
被引数:4
个人简介
"吴延娟,博士,齐鲁工业大学化学与化工学院副教授,硕士生导师,主要从事智能响应型抗癌纳米药物、水凝胶伤口敷料等生物医用高分子材料的研究工作。近年来以第一/通讯作者在Journal of Controlled Release, Biomacromolecules, ACS Applied Nano materials等国际著名材料/化学类期刊发表论文11篇,授权国家发明专利4项。主持国家自然科学基金青年基金、山东省自然科学基金青年基金、齐鲁工业大学培优基金各一项,参与多项国基自然科学基金、山东省自然科学基金。参编外文著作1部。研究领域1. 中草药活性成分纳米化、应用2. 水凝胶伤口辅料3. 诊疗一体化纳米药物的设计、应用科研项目1. 联合用药的顺铂、姜黄素共聚物纳米体系及其化疗协同光动力治疗的研究,山东省自然科学基金博士基金,ZR2018BB050,8万,主持;2. 主链含铂、花菁高分子纳米颗粒用于多模式成像指导下多模式协同治疗的研究,国家自然科学基金青年基金,51803097,25万,主持;3. 基于NO供体/花菁纳米系统综合调控肿瘤微环境增强 NO/PDT/化疗抗肿瘤疗效的研究,齐鲁工业大学科教产培优基金,2023PY051,30万,主持。代表性论文1. Xia Hu ; Jiazhen Wu; Yuanyuan Chang; Mingyang Zhou*; Ling Wang*; Zhaowei Chen ; Yanjuan Wu*; Doxorubicin- and Cisplatin-Based Nanotherapeutic as a Tumor Microenvironment-Biodegradable Nanoplatform for Combined Multidrug Chemotherapy/Chemodynamic/Mild Photothermal Cancer Treatment, 2026, 9(8), 3813-38252. Jiazhen Wu; Xia Hu; Yuanyuan Chang; Zeyuan Sun; Mingyang Zhou; Sijie Song; Zhaowei Chen; Yanjuan Wu*; pH/Reduction/Light-Responsive Nanodrug Based on Perylene Diimide Polyprodrug for Combined Chemotherapy and Photothermal Therapy, ACS Applied Nano Materials, 2025, 8(28): 13981 139923. Jiazhen Wu; Nan Wang; Guozheng Liu; Mingming Luan; Mingyang Zhou; Yanjuan Wu*; Supramolecular ‘‘all-in-one’’ nanodrug based on perylene diimide for dual-mode imaging guided PTT-chemotherapy, New Journal of Chemistry, 2024, 48(24): 11025-110344. Guozheng Liu; Jiazhen Wu; Siyuan Liu; Mingming Luan; Jing Xu; Yanjuan Wu*; Tailoring dual drug-backboned polyurethane prodrug nanoparticles as all-in-one nanomedicine for precise multimodal imaging-guided PTT-chemotherapy, New Journal of Chemistry, 2023, 47(28): 13320 133305. Shuying Li; Yanjuan Wu*; Siyuan Liu; Ting Wu; Guozheng Liu; Tianduo Li; Zhaowei Chen; A multifunctional platinum(IV) and cyanine dye-based polyprodrug for trimodal imaging-guided chemo–phototherapy, Journal of Materials Chemistry B, 2022, 10(7): 1031-1041 6. Yanjuan Wu; Dongfang Zhou; Qingfei Zhang; Zhigang Xie; Xuesi Chen; Xiabin Jing; Yubin Huang; Dual-Sensitive Charge-Conversional Polymeric Prodrug for Efficient Codelivery of Demethylcantharidin and Doxorubicin, Biomacromolecules, 2016, 17(8): 2650-2661"
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
多柔比星和顺铂基纳米治疗剂作为肿瘤微环境降解型纳米平台,用于联合多药化疗/化学动力学/温和光热协同癌症治疗

